Correction to: Can Pharmacokinetic Studies Assess the Pulmonary Fate of Dry Powder Inhaler Formulations of Fluticasone Propionate? (The AAPS Journal, (2021), 23, 3, (48), 10.1208/s12248-021-00569-x)

Günther Hochhaus, Mong Jen Chen, Abhinav Kurumaddali, Uta Schilling, Yuanyuan Jiao, Stefanie K. Drescher, Elham Amini, Simon M. Berger, Bhargava Kandala, Christine Tabulov, Jie Shao, Brandon Seay, Mutasim N. Abu-Hasan, Sandra M. Baumstein, Lawrence Winner, Jagdeep Shur, Robert Price, Michael Hindle, Xiangyin Wei, Cynthia CarrascoDennis Sandell, Oluwamurewa Oguntimein, Minori Kinjo, Renishkumar Delvadia, Bhawana Saluja, Sau L. Lee, Denise S. Conti, Jürgen B. Bulitta

Research output: Contribution to journalComment/debatepeer-review

Abstract

In this article, Simon M. Berger at affiliation Department of Pharmaceutics, College of Pharmacy, University of Florida, 1345 Center Drive, Gainesville, Florida, 32610, USA, was missing from the author list.

Original languageEnglish
Article number1
JournalAAPS Journal
Volume24
Issue number1
DOIs
Publication statusPublished - 28 Feb 2022

ASJC Scopus subject areas

  • Pharmaceutical Science

Fingerprint

Dive into the research topics of 'Correction to: Can Pharmacokinetic Studies Assess the Pulmonary Fate of Dry Powder Inhaler Formulations of Fluticasone Propionate? (The AAPS Journal, (2021), 23, 3, (48), 10.1208/s12248-021-00569-x)'. Together they form a unique fingerprint.

Cite this